A detailed history of Fmr LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 16,159,047 shares of RNA stock, worth $674 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,159,047
Previous 14,241,636 13.46%
Holding current value
$674 Million
Previous $363 Million 81.62%
% of portfolio
0.04%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$22.73 - $40.85 $43.6 Million - $78.3 Million
1,917,411 Added 13.46%
16,159,047 $660 Million
Q1 2024

May 13, 2024

BUY
$9.16 - $25.52 $35.2 Million - $97.9 Million
3,837,540 Added 36.88%
14,241,636 $363 Million
Q4 2023

Feb 13, 2024

SELL
$4.87 - $9.37 $3.46 Million - $6.66 Million
-710,335 Reduced 6.39%
10,404,096 $94.2 Million
Q3 2023

Nov 13, 2023

BUY
$6.3 - $11.35 $3.1 Million - $5.58 Million
491,567 Added 4.63%
11,114,431 $70.9 Million
Q2 2023

Aug 11, 2023

BUY
$10.62 - $17.34 $55.3 Million - $90.2 Million
5,203,807 Added 96.03%
10,622,864 $118 Million
Q1 2023

May 11, 2023

BUY
$15.35 - $25.65 $7.58 Million - $12.7 Million
493,679 Added 10.02%
5,419,057 $83.2 Million
Q4 2022

Feb 13, 2023

BUY
$10.06 - $22.66 $14.6 Million - $32.9 Million
1,453,059 Added 41.85%
4,925,378 $109 Million
Q3 2022

Nov 10, 2022

SELL
$15.46 - $23.43 $5.21 Million - $7.89 Million
-336,804 Reduced 8.84%
3,472,319 $56.7 Million
Q2 2022

Aug 12, 2022

SELL
$11.18 - $20.5 $20,034 - $36,736
-1,792 Reduced 0.05%
3,809,123 $55.3 Million
Q1 2022

May 13, 2022

BUY
$14.2 - $23.78 $488,352 - $817,817
34,391 Added 0.91%
3,810,915 $70.4 Million
Q4 2021

Feb 14, 2022

SELL
$20.4 - $28.66 $1.17 Million - $1.64 Million
-57,143 Reduced 1.49%
3,776,524 $89.8 Million
Q3 2021

Nov 15, 2021

BUY
$18.16 - $25.21 $7.98 Million - $11.1 Million
439,352 Added 12.94%
3,833,667 $94.4 Million
Q2 2021

Aug 13, 2021

BUY
$19.62 - $29.26 $66.6 Million - $99.3 Million
3,394,315 New
3,394,315 $83.9 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.17B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.